Cargando…
伴Ph染色体变异易位初诊慢性髓性白血病慢性期患者的细胞、分子遗传学特征及酪氨酸激酶抑制剂疗效
OBJECTIVE: To investigate the molecular-cytogenetic characterization and impact on tyrosine kinase inhibitors (TKIs) therapy in chronic phase of chronic myeloid leukemia (CML-CP) patients with variant Ph chromosome (vPh). METHODS: The clinical data of 32 patients with vPh chromosomes were collected...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343003/ https://www.ncbi.nlm.nih.gov/pubmed/29562466 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.03.008 |
Ejemplares similares
-
中国服用酪氨酸激酶抑制剂的慢性髓性白血病慢性期患者共存疾病状况及其对患者报告结果的影响
Publicado: (2018) -
慢性髓性白血病酪氨酸激酶抑制剂治疗后出现Ph(−)细胞染色体异常八例临床观察
Publicado: (2016) -
儿童慢性髓性白血病酪氨酸激酶抑制剂停药的研究进展
Publicado: (2023) -
中国慢性髓性白血病慢性期患者报告的酪氨酸激酶抑制相关不良反应及其对日常生活的影响研究
Publicado: (2016) -
妊娠期停用酪氨酸激酶抑制剂对慢性髓性白血病患者疾病状态及生育结果影响的观察
Publicado: (2018)